Tag Archives: Risk Evaluation and Mitigation Strategy

A Job Half Done

Posted on August 4, 2026 by Alyssa Sonnenburg

Overturning Roe was a historic victory, but ending Roe was only step one. Since Dobbs, abortion rates have actually increased—driven largely by unregulated, mail-order chemical abortion drugs that put women and preborn babies at severe risk.

Posted in Federal, Sanctity of Life | Tagged Abortion, abortion drug, Comstock Act, Dobbs, Dobbs v. Jackson Women's Health Center, mifepristone, Planned Parenthood, Risk Evaluation and Mitigation Strategy, Roe v. Wade | Comments Off

Death Coming Soon to A Pharmacy Near You

Posted on February 11, 2023 by David E Smith

As of early January 2023, Danco Laboratories, the U.S. manufacturer of the abortion pill, announced that the FDA has made changes to its guidelines surrounding the abortion pill. These changes allow pharmacies, from large chains like CVS or Walgreens to small, locally owned businesses, to dispense the pill to anyone with a prescription.

Posted in next gen, Sanctity of Life | Tagged abortion pill, Chemical abortion, Danco Laboratories, Dr. Christina Francis, FDA, Mifeprex, mifepristone, misoprostol, Plan B, Risk Evaluation and Mitigation Strategy, RU 486 | Comments Off